Objective To evaluate autonomic nervous function lesions in eyes with type 2 diabetes mellitus by investigating pupil diameters under the natural state and drug-induced dilated conditions and maximum binocular amplitude adjustment. Methods In this prospective cohert study, 80 type 2 diabetic patients from Peking University Shenzhen Hospital were divided into two groups based on the results of fundus fluorescene angiography (FFA), a preclinical group and a non-proliferative group with 40 patients in each group. Thirty age-matched healthy people were selected as controls. Maximum binocular amplitude adjustment was tested with a comprehensive refractometer, pupil diameters under the natural state and drug-induced dilated conditions were measured with corneal topography. A one-way ANOVA was used for data analysis. Results The mean pupil diameters of the two eyes under the natural state in the control group, preclinical group and non-proliferative group were the same, 2.92±0.47 mm, 3.14±0.65 mm, and 3.24±0.58 mm, respectively. The differences between the groups were not statistically significant (F=2.637, P>0.05). For the right eyes, the mean pupil diameters under the drug-induced dilated conditions were 7.28±0.64 mm, 6.66±0.95 mm, and 6.42±1.32 mm, respectively. The differences between the groups were not statistically significant (F=6.008, P<0.05). The mean diameters for the left eyes were 7.37±0.63 mm, 6.50±1.21 mm, and 6.51±1.04 mm, respectively. The differences between the groups were statistically significant (F=7.737, P<0.05). For the right eyes, the mean dilation ratios were 1.56%±0.47%, 1.16%±0.32%, and 0.98%±0.32%, respectively. The differences between the groups were statistically significant (F=21.620, P<0.05). The ratios for the left eyes were 1.59%±0.47%, 1.11%±0.36%, and 1.04%±0.32%, respectively. The differences between the groups were significant (F=20.289, P<0.05). The mean maximum binocular amplitude adjustments were +4.87±2.53 D, +3.01±1.66 D, and +2.38±1.53 D, respectively. The differences between the groups were significant (F=15.478, P<0.05). Further comparison showed that the drug-induced pupil diameter, dilation ratio and maximum binocular amplitude adjustment in the control group were higher than in the preclinical and non-proliferative groups (P<0.05). Conclusion eye sympathetic nerve lesions and eyes symmetry parasympathetic nerve functional lesion occurs early in type 2 diabetes.
章伟利,胡慧丽,李金瑛,吴承高,张纯. 2型糖尿病对眼部自主神经功能的影响[J]. 中华眼视光学与视觉科学杂志, 2016, 18(1): 41-44.
Zhang Weili*,Hu Huili,Li Jinying,Wu Chenggao,Zhang Chun. Type 2 diabetes affects the autonomic nervous system function of the eye. Chinese Journal of Optometry Ophthalmology and Visual science, 2016, 18(1): 41-44. DOI: DOI:10.3760/cma.j.issn.1674-845X.2016.01.009
Lois C, Alvarez-Buylla A. Long-distance neuronal migration in the adult mammalian brain[J]. Science,1994,264(5162):1145-1148. DOI:10.1126/science.8178174.
[2]
Cahill M, Eustace P, de Jesus V. Pupillary autonomic denervation with increasing duration of diabetes mellitus[J]. Br J Ophthalmol,2001,85(10):1225-1230. DOI:10.1136/bjo.85.10.1225.
[3]
赵堪兴,杨培增. 眼科学[M]. 8版. 北京:人民卫生出版社,2013:20.
[4]
Wilkinson CP, Ferris FL 3rd, Klein RE, et al. Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales[J]. Ophthalmology,2003,110(9):1677-1682. DOI:10.1016/S0161-6420(03)00475-5.
[5]
Lee H, Kim Y, Park J. Pupil cycle time and contrast sensitivity in type II diabetes mellitus patients: A pilot study[J]. Indian J Ophthalmol,2011,59(3):201-205. DOI:10.4103/0301-4738.81027.
[6]
Kwon HJ, Kim HY. A pharmacologic pupillary test in the diagnosis of diabetic autonomic neuropathy[J]. Korean J Ophthalmol,2009,23(4):291-295. DOI:10.3341/kjo.2009.23.4.291.
[7]
Lei HL, Yang KJ, Sun CC, et al. Obtained mydriasis in long-term type 2 diabetic patients[J]. J Ocul Pharmacol Ther, 2011,27(6):599-602. DOI:10.1038/eye.2015.47.
[8]
Smith SA, Dewhirst RR. A simple diagnostic test for pupillary abnormality in diabetic autonomic neuropathy[J]. Diabetic Medicine,1986,3(1):38-41. DOI:10.1111/j.1464-5491.1986.tb00703.x.
Yuan D, Spaeth EB, Vernino S, et al. Disproportionate pupillary involvement in diabetic autonomic neuropathy[J]. Clin Auton Res,2014,24(6):305-309. DOI:10.1007/s10286-014-0258-6.
[11]
Adnan, Efron N, Mathur A, et al. Amplitude of accommodation in type 1 diabetes[J]. Invest Ophthalmol Vis Sci,2014,55(10):7014-7018. DOI:10.1167/iovs.14-15376.
[12]
Suheimat M, Mathur A, Pritchard N, et al. Effect of diabetes on amplitude of accommodation[C]//Proceedings VII European/I World Meeting in Visual and Physiological Optics VPOtics. VPOtics,2014:321-324.
[13]
Verrotti A, Prezioso G, Scattoni R, et al. Autonomic neuropathy in diabetes mellitus[J]. FrontEndocrinol (Lausanne),2014,5:205. DOI:10.3389/fendo.2014.00205.